Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection.

Influenza research and treatment

Babapoor S, Neef T, Mittelholzer C, Girshick T, Garmendia A, Shang H, Khan MI, Burkhard P.
PMID: 23074652
Influenza Res Treat. 2011;2011:126794. doi: 10.1155/2011/126794. Epub 2012 Jan 12.

Using peptide nanoparticle technology, we have designed two novel vaccine constructs representing M2e in monomeric (Mono-M2e) and tetrameric (Tetra-M2e) forms. Groups of specific pathogen free (SPF) chickens were immunized intramuscularly with Mono-M2e or Tetra-M2e with and without an adjuvant....

Cite
Babapoor S, Neef T, Mittelholzer C, et al. A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection. Influenza Res Treat. 2012;2011:126794doi: 10.1155/2011/126794.
Babapoor, S., Neef, T., Mittelholzer, C., Girshick, T., Garmendia, A., Shang, H., Khan, M. I., & Burkhard, P. (2011). A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection. Influenza research and treatment, 2011126794. https://doi.org/10.1155/2011/126794
Babapoor, Sankhiros, et al. "A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection." Influenza research and treatment vol. 2011 (2011): 126794. doi: https://doi.org/10.1155/2011/126794
Babapoor S, Neef T, Mittelholzer C, Girshick T, Garmendia A, Shang H, Khan MI, Burkhard P. A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection. Influenza Res Treat. 2011;2011:126794. doi: 10.1155/2011/126794. Epub 2012 Jan 12. PMID: 23074652; PMCID: PMC3447297.
Copy Download .nbib Format: NLM
Malaria Prophylaxis in Different Age Groups.

Journal of travel medicine

Mittelholzer ML, Steffen R, Stürchler D, Wall M.
PMID: 9815460
J Travel Med. 1996 Dec 01;3(4):219-223. doi: 10.1111/j.1708-8305.1996.tb00750.x.

Background: There is a perceived increased health risk in senior visitors to malaria endemic countries. Methods: The authors sought to compare effectiveness and tolerability of malaria chemoprophylaxis in senior travelers (>=60 years) with those in younger travelers (20-59 years)....

Cite
Mittelholzer ML, Steffen R, Stürchler D, et al. Malaria Prophylaxis in Different Age Groups. J Travel Med. 1996;3(4):219-223doi: 10.1111/j.1708-8305.1996.tb00750.x.
Mittelholzer, M. L., Steffen, R., Stürchler, D., & Wall, M. (1996). Malaria Prophylaxis in Different Age Groups. Journal of travel medicine, 3(4), 219-223. https://doi.org/10.1111/j.1708-8305.1996.tb00750.x
Mittelholzer, et al. "Malaria Prophylaxis in Different Age Groups." Journal of travel medicine vol. 3,4 (1996): 219-223. doi: https://doi.org/10.1111/j.1708-8305.1996.tb00750.x
Mittelholzer ML, Steffen R, Stürchler D, Wall M. Malaria Prophylaxis in Different Age Groups. J Travel Med. 1996 Dec 01;3(4):219-223. doi: 10.1111/j.1708-8305.1996.tb00750.x. PMID: 9815460.
Copy Download .nbib Format: NLM
Human BK Polyomavirus Plasmid pBKV (34-2) (Dunlop) Contains Mutations Not Found in the Originally Published Sequences.

Genome announcements

Henriksen S, Mittelholzer C, Gosert R, Hirsch HH, Rinaldo CH.
PMID: 25814590
Genome Announc. 2015 Mar 26;3(2). doi: 10.1128/genomeA.00046-15.

The plasmid pBKV (34-2) (ATCC 45025) contains the entire BK polyomavirus Dunlop genome. Sequencing revealed 12 point mutations compared to the GenBank sequence, but only 4 point mutations compared to the published sequence. The origin of these differences is...

Cite
Henriksen S, Mittelholzer C, Gosert R, et al. Human BK Polyomavirus Plasmid pBKV (34-2) (Dunlop) Contains Mutations Not Found in the Originally Published Sequences. Genome Announc. 2015;3(2)doi: 10.1128/genomeA.00046-15.
Henriksen, S., Mittelholzer, C., Gosert, R., Hirsch, H. H., & Rinaldo, C. H. (2015). Human BK Polyomavirus Plasmid pBKV (34-2) (Dunlop) Contains Mutations Not Found in the Originally Published Sequences. Genome announcements, 3(2), . https://doi.org/10.1128/genomeA.00046-15
Henriksen, Stian, et al. "Human BK Polyomavirus Plasmid pBKV (34-2) (Dunlop) Contains Mutations Not Found in the Originally Published Sequences." Genome announcements vol. 3,2 (2015). doi: https://doi.org/10.1128/genomeA.00046-15
Henriksen S, Mittelholzer C, Gosert R, Hirsch HH, Rinaldo CH. Human BK Polyomavirus Plasmid pBKV (34-2) (Dunlop) Contains Mutations Not Found in the Originally Published Sequences. Genome Announc. 2015 Mar 26;3(2). doi: 10.1128/genomeA.00046-15. PMID: 25814590; PMCID: PMC4384130.
Copy Download .nbib Format: NLM
Mefloquine in the Prophylaxis of P. Falciparum Malaria.

Journal of travel medicine

Coulibaly A, Haller L, Mittelholzer ML, Soro BN, Sossouhounto RT, Stuerchler D.
PMID: 9815395
J Travel Med. 1995 Dec 01;2(4):221-224. doi: 10.1111/j.1708-8305.1995.tb00663.x.

Background: The objectives of this study were (1) to compare the efficacy of Lariam (mefloquine) with that of Fansimef (mefloquine, sulfadoxine, and pyrimethamine), Fansidar (sulfadoxine and pyrimethamine), chloroquine, and placebo in suppressing asexual parasitemia in semi-immune persons living in...

Cite
Coulibaly A, Haller L, Mittelholzer ML, et al. Mefloquine in the Prophylaxis of P. Falciparum Malaria. J Travel Med. 1995;2(4):221-224doi: 10.1111/j.1708-8305.1995.tb00663.x.
Coulibaly, A., Haller, L., Mittelholzer, M. L., Soro, B. N., Sossouhounto, R. T., & Stuerchler, D. (1995). Mefloquine in the Prophylaxis of P. Falciparum Malaria. Journal of travel medicine, 2(4), 221-224. https://doi.org/10.1111/j.1708-8305.1995.tb00663.x
Coulibaly, et al. "Mefloquine in the Prophylaxis of P. Falciparum Malaria." Journal of travel medicine vol. 2,4 (1995): 221-224. doi: https://doi.org/10.1111/j.1708-8305.1995.tb00663.x
Coulibaly A, Haller L, Mittelholzer ML, Soro BN, Sossouhounto RT, Stuerchler D. Mefloquine in the Prophylaxis of P. Falciparum Malaria. J Travel Med. 1995 Dec 01;2(4):221-224. doi: 10.1111/j.1708-8305.1995.tb00663.x. PMID: 9815395.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries